Philippe Moingeon
17Patents
1h-index
25Co-inventors
50Inventor score
Filing activity: Oct 20, 2000 → Jan 26, 2017
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8017590B1 | Method of inducing and/or enhancing an immune response to tumor antigens | Chemistry; Metallurgy | 15 | Expired |
| US9480748B2 | Mucoadhesive particulate formulation for inducing antigen-specific immune tolerance | Human Necessities | 1 | Active |
| US9187568B2 | Use of IgG1 immunoglobulins and/or ligands of the CD32 receptor for treating inflammatory diseases and manifestations via the mucosal route | Chemistry; Metallurgy | 1 | Active |
| US10101341B2 | Biomarkers of immunotherapy efficacy | Physics | 1 | Active |
| US8632993B2 | Method for grass species identification | Physics | 1 | Active |
| US7851212B2 | Immunogenic polypeptides encoded by MAGE minigenes and uses thereof | Chemistry; Metallurgy | 1 | Expired |
| US9795644B2 | Reduction of in vitro genotoxicity of pollen extracts by removal of flavonoids | Human Necessities | 0 | Active |
| US10884002B2 | Sialylated fetuin-A as a marker of immunotherapy efficacy | Physics | 0 | Active |
| US9822185B2 | Use of IGG1 immunoglobulins and/or ligands of the CD32 receptor for treating inflammatory diseases and incidents via the mucosa | Chemistry; Metallurgy | 0 | Active |
| US9555102B2 | Compositions for antigen-specific induction of tolerance | Human Necessities | 0 | Active |
| US9868770B2 | Recombinant Der P 2 expressed in Pichia Pastoris as a “natural-like” allergen for immunotherapy and diagnostic purposes | Chemistry; Metallurgy | 0 | Active |
| US11027010B2 | Reduction of in vitro genotoxicity of pollen extracts by removal of flavonoids | Human Necessities | 0 | Active |
| US11015221B2 | Markers of immune response | Chemistry; Metallurgy | 0 | Active |
| US10190166B2 | Methods for identifying dendritic cell subsets, for determining if a patient is developing a regulatory or an effector immune response, and for determining response to immunotherapy | Chemistry; Metallurgy | 0 | Active |
| US10610586B2 | Compositions for antigen-specific induction of tolerance | Human Necessities | 0 | Active |
| US8257717B2 | Immunogenic polypeptides encoded by MAGE minigenes and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US11028441B2 | IL-10 as a predictive biomarker of responsiveness to house dust mite allergen immunotherapy | Physics | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.